1. Cilostazol is associated with improved outcomes after peripheral endovascular interventions 
Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J. Larson, MD, MPH, David H. Stone, MD, Richard J. Powell, MD, Daniel B. Walsh, MD, Philip P. Goodney, MD, MS 
Journal of Vascular Surgery 
Volume 59, Issue 6, Pages (June 2014)
DOI: /j.jvs
Copyright © 2014 Society for Vascular Surgery Terms and Conditions

2. Fig 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2014 Society for Vascular Surgery Terms and Conditions

3. Fig 2 Newcastle-Ottawa quality assessment scale.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2014 Society for Vascular Surgery Terms and Conditions

4. Fig 3 Cochrane risk-of-bias tool.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2014 Society for Vascular Surgery Terms and Conditions

5. Fig 4
Restenosis after peripheral vascular intervention (PVI). RCT, Randomized controlled trial.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2014 Society for Vascular Surgery Terms and Conditions

6. Fig 5 Forest plot of main outcomes. CI, Confidence interval.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2014 Society for Vascular Surgery Terms and Conditions

7. Fig 6
Forest plot of mortality outcomes. CI, Confidence interval; RCT, randomized controlled trial.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2014 Society for Vascular Surgery Terms and Conditions